Xconomy

SEPTEMBER 30, 2016

Who will be first to market with a new type of cancer treatment known as CAR-T? TOP STORIES : —Kite Pharma (NASDAQ: KITE ) released data from an ongoing non-hodgkin lymphoma trial that, while early, bolster the view that the Santa Monica, CA, company could be the first to market with a cell-based immunotherapy product known as CAR-T.

Avalon 40

Avalon Thousand Oaks Study Startup 40

socalTECH

APRIL 29, 2014

Our first project was 3D imaging of the heart, so that doctors could study a pacemaker and defibrillator recall from the Alfred E. The concept of the incubator is we''re raising a fund here locally and ten percent is local the other 90 percent on AngelList, and we''ll be locating here in the town of Thousand Oaks.

Startup 262

Startup Competition Software Review UCLA 262

Xconomy

JUNE 10, 2016

. —Two more clinical setbacks decimated the shares of Massachusetts biotechs: Ocular Therapeutix’s (NASDAQ: OCUL ) OTX-DP failed a trial for allergic conjunctivitis , while Catabasis Pharmaceuticals’ (NASDAQ: CATB ) CAT-2054 flunked a study in patients with high cholesterol. The full data set has yet to be released.

Incubator 67

Incubator Thousand Oaks Screening Pricing 67

SoCal Delicious

APRIL 5, 2010

Smith Professorship in Land Use Studies, and the Martin V. • Jack Gilbert , once the chief executive officer of a large Los Angeles-based corporation, later founded Thousand Oaks Land Development and played a major role in the development of Thousand Oaks area, leading that city’s emergence as a major business and corporate center.

Santa Barbara 53

Santa Barbara Thousand Oaks Oracle Ventura 53